About Ornim
Ornim is a company based in Lod (Israel) founded in 2004. It operates as a B2B. Ornim has raised $65 million across 3 funding rounds from investors including GE Healthcare, General Electric and Fosun. Ornim operates in a competitive market with competitors including PD Neurotechnology, iota Biosciences, Winterlight Labs, Cognoptix and NeuroVision, among others.
- Total Equity Funding$65M (USD)
in 3 rounds
- Latest Funding Round$20M (USD), Series C
Aug 2016
- InvestorsGE Healthcare
& 6 more
Funding Insights of Ornim
Ornim has successfully raised a total of $65M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $20 million completed in August 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $65M
- Total Rounds 3
- Last Round Series C — $20M
- First Round $20M
(Aug 2012)
- Investors Count 7
All 3 funding rounds of Ornim with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2016 | $20M | Series C | – | Longtech Ventures | |
| Oct 2015 | $25M | Series C | – | – | |
| Aug 2012 | $20M | Series B | – | Orbimed, Mac Fund | – |
7 investors in total: 7 institutional.
Investors in Ornim
Ornim has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include GE Healthcare, General Electric and Fosun.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields. | 1989 | orbimed.com | New York, United States | |
Growth capital is provided to mature MedTech companies by Agate. | – | agate-invest.com | Tel-Aviv, Israel | |
- | – | longtechmed.com | - | |
- | – | mac-vc.com | - | |
Diversified operations are conducted across multiple industries worldwide. | 1892 | ge.com | United States | |
Diversified investment, asset management, and insurance services are offered globally. | 1992 | fosun.com | Shanghai, China | |
Materials management solutions are provided for healthcare organizations. | 1892 | gehealthcare.com | Chicago, United States |
Investor details for Ornim
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Ornim
3 dated milestones of Ornim across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Ornim is founded.
- Funding First funding round of $20.0M.
- Funding Latest funding round, Series C, of $20.0M.
Competitors of Ornim
Ornim operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PD Neurotechnology, iota Biosciences, Winterlight Labs, Cognoptix and NeuroVision, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pdneurotechnology.com | 2015 | London, United Kingdom | $93.34M | 32 | A wearable device is developed to monitor Parkinson's movement disorders. | |
| iota.bio | 2017 | Berkeley, United States | $15M | – | Developer of neurodiagnostic techniques | |
| winterlightlabs.com | 2015 | Toronto, Canada | $5.73M | – | Cognitive impairment signs are detected through speech sample analysis. | |
| cognoptix.com | 2001 | Acton, United States | $41.28M | 2 | Non-invasive eye scans for early Alzheimer's detection are developed. | |
| neurovision.com | 2010 | Sacramento, United States | $31.6M | 13 | AI based retinal imaging analysis for Alzheimer's and eye disease | |
| synapdx.com | 2010 | Southborough, United States | $32.75M | – | Online platform offering HGH injections for energy, performance, and anti-aging. | |
| physiosonics.com | 2000 | Seattle, United States | $11.5M | – | Ultrasound imaging is developed for brain blood flow monitoring. | |
| mjn.cat | 2014 | Blanes, Spain | $630,719 | – | A wearable device is developed to evaluate epileptic seizure risk. | |
| oxyprem.com | 2018 | Zurich, Switzerland | $130,754 | – | A non-invasive device for measuring brain oxygen levels is developed. |
Detailed competitors of Ornim
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Ornim
10 companies that operate in the same segment as Ornim (Hematology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Catheter-based thrombectomy devices for vascular emboli removal are developed. | 2011 | Irvine, California, United States | USD 51.89 M | USD 493.63 M | 696 | |
Small activating RNA therapeutics are developed to restore gene function. | 2008 | London, England, United Kingdom | USD 460.41 M | USD 23.07 M | 37 | |
Small molecules are developed to treat hematologic and musculoskeletal disorders. | 2016 | Lexington, Kentucky, United States | USD 90 M | USD 244.06 M | 169 | |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders | 2016 | Menlo Park, California, United States | USD 442 M | – | 66 | |
Developer of therapeutics for the treatment of hematologic diseases | 2017 | Cambridge, Massachusetts, United States | USD 140 M | – | 84 | |
Gene therapy platform is developed for chronic disease treatments. | 2015 | Stevenage, Hertfordshire, United Kingdom | USD 273.69 M | USD 435.87 K | 152 | |
Novel anticoagulants for thrombosis treatment are developed. | 2019 | Cambridge, Massachusetts, United States | USD 250 M | – | 14 | |
Developer of therapies for treating hemochromatosis & beta thalassemia | 1989 | San Diego, California, United States | – | USD 75.72 M | 71 | |
Breakthrough therapies are developed for blood diseases and infections. | 2014 | Buffalo, New York, United States | USD 1 M | – | 22 | |
Hematology products and solutions are provided for medical applications. | 1971 | Braintree, Massachusetts, United States | – | USD 1.33 B | 3,020 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ornim
Ornim was founded in 2004 and raised its 1st funding round 8 years after it was founded.
Ornim is headquartered in Lod, Israel. It is registered at Lod, Central District, Israel.
Ornim is a funded company, having raised a total of $65M across 3 funding rounds to date. The company's 1st funding round was a Series B of $20M, raised on Aug 2012.
Ornim provides non-invasive solutions for measuring cerebral and tissue blood flow through providing healthcare solutions, developing medical devices, diagnostic tools, and blood flow measurement. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Ornim's top competitors include iota Biosciences, PD Neurotechnology and Winterlight Labs.
Ornim has 7 investors. Key investors include GE Healthcare, General Electric, Fosun, Orbimed, and Agate Medical Investments.